Information for Authors
Archive of Oncology

Founded 1993
© Oncology Institute of Vojvodina, Serbia
Submission of Manuscript
Proofs
Protection of research human and animal subjects
Article Types
Other Submissions
Journal Style
Digital Object Indentifier
Copyright
Download Information for authors
Click here to download (280K)




These guidelines are in accordance with the Uniform Requirements for Manuscript Submitted to Biochemical Journals (April 2010). The complete information for authors can be found on our Web site http://www.onk.ns.ac.rs/archive/instruct.htm.

AIMS AND SCOPE

The Archive of Oncology is an international comprehensive oncology journal that publishes editorials, original research, review articles, case reports, special articles on clinical oncology, experimental oncology, cancer epidemiology and prevention, and social and ethical aspects of cancer. The editorial board strictly adheres to the principles of Good Scientific Practice related to the publishing policy. Authors are kindly asked to read the following information in advance of manuscript preparation and submission. Manuscripts that are not written according to this information will be sent back to authors in order to make corrections before sending them to reviewers.

EDITORIAL POLICY

The journal publishes editorials, research articles, review articles, clinically relevant studies, special articles, case reports, imaging in oncology, letters to the editor, commentary, and book reviews. All submitted manuscripts will be reviewed by at least two reviewers and, when necessary, a statistician. Authors will be notified of acceptance, rejection, or need for revision not later than 4 weeks after submission.
SUBMISSION OF MANUSCRIPTS
The preferred file format is Word (.doc or .docx). Acceptable formats for pictures, photographs and figures are .jpg, and .tif. Please do not send pdf files. Send 2 hard copies of the manuscript and its electronic version (e-mail, CD-ROM). The disc must be marked with names of the authors, and the format and word processor program used. In the electronic version, separate files should be used for the text, figures, and tables.
The Manuscript should be prepared in double-spaced 12-pt font, preferably Arial and Times New Roman, on single-column, single sided, providing 25 mm margins. Number the pages of the manuscript successively, beginning with the title page as page 1. Each following segment of the manuscript (e.g. Introduction, Methods, Results, etc.) has to start on the next separated page.

TITLE PAGE. The title page should include a concise but informative title, the authors' full names, the department/institution and each author's address with the symbol to link authors and their addresses. Also, the title page must include the name, address, fax and telephone numbers, e-mail of the author to whom correspondence should be addressed, details of source of support in the form grant, equipment and drugs, word counts (for the abstract and the text without the abstract), the number of figures and tables.

ABSTRACT. The abstract starts on the second page. Original articles must contain a structured abstract of up to 300 words, titled Background, Methods, Results, and Conclusion. Structured abstracts are not required in review articles, case reports, and other contributions.

KEY WORDS. Include 3 to 6 key words below the abstract, taken from the Medical Subject Headings (MeSH).

COVERING LETTER. An example of the covering letter: "Those undersigned claim that the manuscript has not been published elsewhere as a whole, or partly. We agree with the content of the manuscript and approve its publication in the Archive of Oncology. Researching has been approved by the institutional Ethics Committee. There are no financial problems that might lead to a conflict of interest."
As for the previous publications, please provide that no substantial part of the manuscript may have been or may be published elsewhere. This restriction does not apply to abstracts or press reports published in connection with scientific meetings. For advice on previous or simultaneous publication, contact the Editorial Office.

CONFLICT OF INTEREST. Declaration of Competing Interest Form can be downloaded from the website (http://www.onk.ns.ac.rs/archive/Declaration.pdf):
Click here to download (20K).

PROOFS
Proofs in PDF format will be sent to the corresponding author via e-mail and should be returned within 48 hours of receipt. Sending of corrected proof by fax should be avoided. Corrections should be restricted to typewriting errors as any substantial changes other than these may be charged to the author. The responsibility of defeating errors is with the author.

PROTECTION OF RESEARCH HUMAN AND ANIMAL SUBJECTS
When reporting experiments on human subjects, indicate whether the procedures applied were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) or with the Helsinki Declaration (1964, amended in 1975, 1983, 1989, 1996, and revised in 2000) of the World Medical Association. Do not use patients' names, initials, or hospital numbers, especially in any illustrative material. When reporting experiments on animals, indicate whether the institution's or the National Research Council's guide for, or any national law on the care and use of laboratory animals was followed.

ARTICLE TYPES
Articles should be written according to the unique rules for manuscripts published in biomedical journals, published by the International Committee of Medical Journal Editors (Vancouver style) in www.icmje.org (Serbian translation taken from the Serbian Archive, special issue 1999;127:88).


RESEARCH ARTICLES. Research articles are scientific reports of the results of original clinical or experimental research. The text is limited to 3,000 words, with structured abstract up to 300 words, maximum of 5 tables and figures (total), and up to 50 references.

CLINICAL TRIALS. All randomized controlled trials submitted for publication in the Archive of Oncology should include a completed Consolidated Standards of Reporting Trials (CONSORT) flow chart. Please refer to the CONSORT statement website at: http://www.consort-statement.org/ for more information.
Clinical trials should be registered in accordance with the criteria outlined by the International Committee of Medical Journal Editors, including the June 2007 update. (http://www.icmje.org/clin_trial.pdf).

META-ANALYSES. Meta-analyses are reviews of randomized trials. Authors are encouraged to submit QUOROM Statement (Quality of Reporting of Meta-analyses) which consists of a checklist and flow diagram) or the MOOSE (Meta-analysis of Observational Studies in Epidemiology). See: http://www.consort-statement.org.

REVIEW ARTICLES. The editor generally solicits reviews. These manuscripts summarize the state-of-the-art in a particular field. They should contain no more than 4,000 words, up to 75 references, maximum of 5 tables and figures (total), and a non-structured abstract of up to 300 words.

CASE REPORTS. These articles should contain no more than 2,000 words, excluding the references (up to 25), a non-structured abstract of up to 200 words, and up to 3 figures. There should be no more than five authors. A written consent for publication must be obtained from the patient.


OTHER SUBMISSIONS

EDITORIALS. Editorials may express opinions on any subject relevant to the journal's aims and scope, or may comment the significance of articles in the same issue of the journal. The editors usually commission editorials, but we are happy to consider unsolicited submissions also. Editorials should contain about 1,200 words but its length may be negotiated at the time of invitation, and up to 15 references. An abstract is not required.

SPECIAL ARTICLE. Articles on clinical oncology, experimental oncology, cancer epidemiology and prevention, and social and ethical aspects of cancer. Recommended: an unstructured abstract of 200 words, and no more than 3,000 words of the article itself.

IMAGING IN CLINICAL ONCOLOGY are classic images of common medical conditions. Visual images are important part of much of what we do and learn in medicine. This feature is intended to capture the sense of visual discovery and variety that physicians experience. Imaging in clinical oncology are not intended as a vehicle for case reports.

LETTERS TO THE EDITOR. Letters are welcome and will be published if appropriate. They should be no longer than 500 words and a maximum of 10 references and 1 figure or table.

COMMENTARY. These manuscripts describe an important topic in oncology which is not linked to a specific article. Recommended lenght: up to 2,000 words and 1 table or figure, and no more than 25 references.

BOOK REVIEWS. Book reviews are solicited by the book review editor. Unsolicited book reviews are welcome and contain up to 500 words.

ERRATA
Any substantial error in a published paper will be corrected as soon as possible.

SUPPLEMENTS / PROCEEDINGS OF SYMPOSIA
Papers from meetings can be published as an extended supplement to the journal, providing for the full expenses of such supplements. Supplements are accepted for publication on the discretion of the Editor-in-Chief if they are to adhere to editorial policy and acceptance standards, and be subject to peer review.


JOURNAL STYLE

TABLES. Each table with a brief title should be typed double-spaced on a separate sheet of paper at the end of your file. Number tables consecutively (with Arabic numerals) in the order of their first citation in the text. Give each column a short or abbreviated heading. Place explanations in legends of all nonstandard abbreviations used in the table (up to 40 words).
For units and measurements see the paragraph below. Do not use internal horizontal and vertical rules. Always separate the individual columns using tabulators, not a space bar, i.e. tables must be in text format.

FIGURES. Line drawings, diagrams and halftone illustrations (photographs, photomicrographs, etc.) should be designated as figures. They should also be listed on a separate sheet and numbered consecutively with Arabic numerals according to the order in which they have been first cited in the text. Figures should be professionally drawn (not simply typewritten) and photographed. Each figure should be labeled on its back indicating the number of the figure, last name and the first letter of the author, and the topside of the figure.
Photographs should be supplied in 2 copies. Photomicrographs must have internal scale markers, and symbols, arrows or letters should contrast with the background. Photographs of patients must conceal their identity unless patients' written consent for publishing the photograph is obtained. If you borrow or use already published photographs, please submit a written permission for reproduction. Permission is not required for the documents in the public domain.
Figures will not be returned unless requested. Captions and detailed explanations of the figures should be given in the legends. If symbols, arrows, numbers, or letters are used to identify parts of the figure, identify and explain each one clearly in the legend.
Submit the text and tables of each manuscript as a single file, but place all figures, charts etc., in separate files. Allowed graphic formats are EPS, JPG, and TIF. The figures should be either 8.5 cm or 18.0 cm in size, their minimal resolution 300 dpi. Please send original photographs, do not send photocopies.

ACKNOWLEDGEMENTS. Acknowledgments should precede the reference list, specifying general support by a department chairman, acknowledgements of technical help and of financial and material support.

PERMISSIONS. The author must obtain a permission to reproduce figures, tables, and the text of the previously published material, even if that is the author's own work. A written permission must be obtained from the original copyright holder (generally the publisher, not the author or editor) of the journal or book concerned. An appropriate credit should be included in the reference list. A written permission must be obtained from the author of any unpublished material cited from other institutions and should accompany the manuscript. Sending proofs by fax should be avoided.

FOOTNOTES. Footnotes to the title page and the text are to be designated consecutively with superscript Arabic numerals.

ADDENDA. Data acquired after acceptance of the paper, by the authors themselves or by others, cannot be added to the text. An addendum may be included at the proof stage as a "note added in proof", preceding the reference section. However, such addenda are subject to approval by the Editor-in-Chief and could result by delay of publication. Addenda should be kept extremely brief.

UNITS OF MEASUREMENT. Authors should use the SI units. Authors should express all measurements in conventional units, with Systéme International (SI) units (http://www.bipm.org/en/si) given in parentheses throughout the text, or authors may consult Units, symbols and abbreviations: a guide for biological and medical editors and authors, 5th ed., London: Royal Society of Medicine, 1994, or Trpinac P, Savin S, Medakoviæ B. Internacionalni sistem mernih jedinica (IS) u medicini i farmaciji, Beograd-Zagreb: Praxis Medica, Medicinska knjiga, 1979. Also, see http://clincancerres.aacrjournals.org/misc/ifora.shtml.
Figures and tables should use conventional units, with conversion factors given in legends or footnotes.

ABBREVIATIONS AND SYMBOLS. The Archive of Oncology accepts Standard Journal of Biological Chemistry Abbreviations. Generally, avoid abbreviations in the title. In the text, whenever possible, use standard abbreviations. However, if non-standard abbreviations are used, the full term of which an abbreviation stands for should precede its first use in the text. A list of abbreviations and acronyms accepted for use in the Archive of Oncology can be downloaded from the following URL: http://www.aacr.org/pdf_files/Accepted_Abbreviations_Acronyms_2004.pdf.

DRUG NAMES. Use generic names for drugs. Commercial names may be included in parenthesis at first mention in the text. Authors may consult http://www.alims.gov.rs. Complicated drug names or regimens may be abbreviated, with the abbreviation in parenthesis after first mention.

GENE NOMENCLATURE. The Archive of Oncology does not italicize the symbols designating genes, alleles, or loc. All Human Gene Mapping designations for human genes should be capitalized.

BIOCHEMICAL NOMENCLATURE. For biochemical nomenclature, authors may consult www.iubmb.unibe.ch.

MICROARRAY AND PROTEOMIC DATA. The Archive of Oncology requires that the manuscripts describing microarray data are prepared to supply peer reviewers with the data in a format that conforms to the Minimum Information About a Microarray Gene Experiment (MIAME) guidelines of the Microarray Gene Expression Data society (MGED) (http://www.mged.org/Workgroups/MIAME/miame.html). Authors are also encouraged to deposit the data with either the GEO (http://www.ncbi.nlm.nih.gov/projects/geo) or Array Express (http://www.ebi.ac.uk) public archives.

PROTEOMIC ANALYSES. See Biomolecular Interaction Network Database (http://bind.ca).

SEQUENCE INFORMATION. The authors of a manuscript containing new nucleotide and/or aminoacid sequences are asked to deposit the sequence information with the GenBank database (http://www.ncbi.nlm.nih.gov/Genbank/submit.html), or to either the European Molecular Biology Laboratory (EMBL) database (http://www.ebi.ac.uk/embl/Submission), or the DNA Databank of Japan (http://www.ddbj.nig.ac.jp/sub-e.html).

GUIDELINES FOR STEM CELL RESEARCH. Research with embryonic stem cells should adhere to the National Academies' Guidelines for Human Embryonic Stem Cell Research, as published in the National Academies Press.

TUMORS. Authors are advised to use the TNM staging system approved by the International Union Against Cancer and the American Joint Committee on Cancer.

STATISTICAL GUIDELINES. The methods of statistical analysis describe sufficient details on the analyses carried out to enable reader to reproduce the analysis if the data were available. Authors should identify and cite all computer programs or statistical packages used in the analysis, and measures of precision and uncertainty for all statistical estimates. The word "significant" should be used only for statistically significant results. A p-value or confidence interval (CI) or other measures should be cited in the text for any statistically significant finding reported. Outcome variables should be given as estimates, with 95% confidence intervals rather than standard deviations or standard errors.
The statistical analysis may be performed using the regression analysis, adjust/trends, and explanations for insufficient data. For clinical trials, it is necessary to report: important study dates, sample size, interim analyses, compliance to treatments, patient accounting, and characteristics, follow-up, toxicity, and negative studies.
See:
Bailar JC III, Mosteller F. Guidelines for statistical reporting in articles for medical journals. Amplifications and explanations. Ann Interna Med. 1988;108:266-73.
Altman DG. Statistic in medical journals: some recent trends. Statistic Med. 2000;19:3275-89.
Moher D, Schultz KF, Altman DF, CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Clin Oral Investig. 2003;7:2-7.
Cummings P, Rivara FP. Reporting Statistical Information in Medical Journal Articles Arch Pediatr Adolesc Med. 2003;157:321-4 (http://archpedi.ama-assn.org/cgi/content/full/157/4/321).
Hadživukoviĉ S. Statistika. 3rd ed. Beograd: Privredni pregled; 1989.

REFERENCES. The Archive of Oncology reference style follows the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org). Authors should consult the List of Journals Indexed for MEDLINE for standard abbreviations of journals (http://www.nlm.nih.gov/tsd/serials/lji.html).
Authors are responsible for accuracy of the literature data. References should be listed in a separate section immediately following the text. Only references important for the study should be cited. Number references in the order of their first mention in the text. Cite only the number assigned to the reference, not the author. Try to avoid using abstracts as references, but if so, after the titles note (abstr.). The abstract cited should not be more than two years old.
Examples of correct forms of references (for details see: http://www.nlm.nih.gov/bsd/uniform_requirements.html):

Journal article
The first 6 authors are listed; thereafter add et al.
Example:
Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002 Jul 25;347(4):284-7.

As an option, if a journal carries continuous pagination throughout a volume (as many medical journals do) the month and issue number may be omitted.
Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

More than six authors:
Rose ME, Huerbin MB, Melick J, Marion DW, Palmer AM, Schiding JK, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 2002;935(1-2):40-6.

Optional addition of a database's unique identifier for the citation:
Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002 Jul 25;347(4):284-7. PubMed PMID: 12140307.

If the journal has a continuous page numbering, you may omit the issue number, but if it is not the case, add the month and date between the year of publication and the volume number.

Books and chapter citations
Examples:
Personal author(s)
Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. 4th ed. St. Louis: Mosby; 2002.

Editor(s), compiler(s) as author
Gilstrap LC 3rd, Cunningham FG, VanDorsten JP, editors. Operative obstetrics. 2nd ed. New York: McGraw-Hill; 2002.

Author(s) and editor(s)
Breedlove GK, Schorfheide AM. Adolescent pregnancy. 2nd ed. Wieczorek RR, editor. White Plains (NY): March of Dimes Education Services; 2001.

Chapter in a book
Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113.

Dissertations and thesis
Bogdanoviĉ-Stojanoviĉ D. Magnetic resonance mammography in comparison to other radiological methods for differentiating lesions in breast saving surgeries [dissertation]. Novi Sad, Serbia: University of Novi Sad; 2007.

References to information on the Internet
References to information available on the Internet are not considered legitimate references because they are not permanent and generally are not peer-reviewed. If the authors feel that such information would be valuable to the readers, the URL should be cited in a footnote.

Articles in journals:
Abood S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [Internet]. 2002 Jun [cited 2002 Aug 12];102(6):[about 1 p.]. Available from: http://www.nursingworld.org/AJN/2002/june/Wawatch.htmArticle
Notice: Only first words of the article title and words that normally begin with a capital letter are capitalized.

In press / Forthcoming
Note: NLM prefers "Forthcoming" rather than "In press" because not all items will be printed.
Tian D, Araki H, Stahl E, Bergelson J, Kreitman M. Signature of balancing selection in Arabidopsis. Proc Natl Acad Sci U S A. Forthcoming 2002.

Unpublished material
Papers in preparation or submitted for publication, unpublished data, and personal communications should be cited in a footnote, not in the reference section. The names of all authors should be given, along with manuscript titles if possible. Permission must be obtained from persons cited in a personal communication.

DIGITAL OBJECT IDENTIFIER. The Archive of Oncology assigns a unique digital object identifier (DOI) to every article it publishes. The DOI initiative is an international effort for electronic content identification and is guided by the International DOI Foundation, composed primarily of academic publishers and societies. The DOI appears on the title page of the article. The DOI should be cited in a reference as follows:
Article with a Digital Object Identifier (DOI):
Zhang M, Holman CD, Price SD, Sanfilippo FM, Preen DB, Bulsara MK. Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study. BMJ. 2009 Jan 7;338:a2752. doi: 10.1136/bmj.a2752. PubMed PMID: 19129307; PubMed Central PMCID: PMC2615549.
COPYRIGHT. All the material published in the Archive of Oncology represents the opinions of the authors and does not reflect the opinions of the Oncology Institute of Vojvodina, the editors, or the institutions with which the authors are affiliated.
Authors submitting manuscripts to the Archive of Oncology do so with the understanding that if their manuscript is accepted, the copyright in the article, including the right to reproduce the article in all forms and media, shall be assigned exclusively to the publisher (The Oncology Institute of Vojvodina), and that the corresponding author and all coauthors will be required to sign and submit a copyright transfer at the time of submission of the revised manuscript. The Archive Oncology authors retain a number of the nonexclusive rights to their published article.
The copyright transfer agreement can be downloaded from www.onk.na.ac.rs/Archive.
All requests to reproduce or make available anything in the journal as a whole or in its selected part, in electronic or in any other form, should be sent to:

Archive of Oncology
Oncology Institute of Vojvodina
Put doktora Goldmana 4, 21204 Sremska Kamenica, Serbia,
Phone: +381 21 480 5577
Fax: +381 21 6613 741
E-mail:
archive@onk.ns.ac.rs and bogdanovic.gordana@onk.ns.ac.rs

Manuscripts should be submitted to the following address: The Oncology Institute of Vojvodina, ARCHIVE OF ONCOLOGY, Attn.: Dr. Gordana Bogdanoviĉ, Editor-in-Chief, Put doktora Goldmana 4, 21204 Sremska Kamenica, Serbia, e-mail:
archive@onk.ns.ac.rs.

Publishing of papers in the Archive of Oncology is free of charge
 
Last updated December 19, 2013